CRISPR THERAPEUTICS AG Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CRISPR THERAPEUTICS AG (CRSP) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 16.77 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-03
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-06-30 was 16.77M shares, a 72.17% increase year-over-year.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 17.11M shares, a 64.10% increase year-over-year.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 9.74M shares, a 4.54% increase year-over-year.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 10.43M shares, a 12.67% increase year-over-year.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 8.72M shares, a 10.11% decline from fiscal 2024.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 9.71M shares, a 7.82% increase from fiscal 2023.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 9.00M shares, a 4.98% increase from fiscal 2022.
- CRISPR THERAPEUTICS AG antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 8.57M shares, a 329.06% increase from fiscal 2021.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.77M shares 10-Q · filed 2026-08-03 | 16.77M shares 10-Q · filed 2026-08-03 | |||||
| 2026-03-31 | 17.11M shares 10-Q · filed 2026-05-04 | ||||||
| 2025-12-31 | 8.72M shares 10-K · filed 2026-02-12 | ||||||
| 2025-09-30 | 8.78M shares 10-Q · filed 2025-11-10 | ||||||
| 2025-06-30 | 9.74M shares 10-Q · filed 2026-08-03 | 9.74M shares 10-Q · filed 2026-08-03 | |||||
| 2025-03-31 | 10.43M shares 10-Q · filed 2026-05-04 | ||||||
| 2024-12-31 | 9.71M shares 10-K · filed 2026-02-12 | ||||||
| 2024-09-30 | 8.99M shares 10-Q · filed 2024-11-05 | 8.99M shares 10-Q · filed 2025-11-10 | |||||
| 2024-06-30 | 9.32M shares 10-Q · filed 2025-08-04 | 9.32M shares 10-Q · filed 2025-08-04 | |||||
| 2024-03-31 | 9.26M shares 10-Q · filed 2025-05-06 | ||||||
| 2023-12-31 | 9.00M shares 10-K · filed 2026-02-12 | ||||||
| 2023-09-30 | 8.73M shares 10-Q · filed 2024-11-05 | 8.73M shares 10-Q · filed 2024-11-05 | |||||
| 2023-06-30 | 8.89M shares 10-Q · filed 2024-08-05 | 8.89M shares 10-Q · filed 2024-08-05 | |||||
| 2023-03-31 | 9.61M shares 10-Q · filed 2023-05-08 | ||||||
| 2022-12-31 | 8.57M shares 10-K · filed 2025-02-11 | ||||||
| 2022-09-30 | 8.58M shares 10-Q · filed 2023-11-06 | 8.58M shares 10-Q · filed 2023-11-06 | |||||
| 2022-06-30 | 8.91M shares 10-Q · filed 2023-08-07 | 8.91M shares 10-Q · filed 2023-08-07 | |||||
| 2022-03-31 | 9.38M shares 10-Q · filed 2023-05-08 | ||||||
| 2021-12-31 | 2.00M shares 10-K · filed 2024-02-21 | ||||||
| 2021-09-30 | 8.91M shares 10-Q · filed 2022-11-01 | 1.71M shares 10-Q · filed 2022-11-01 | |||||
| 2021-06-30 | 2.33M shares 10-Q · filed 2022-08-08 | 1.69M shares 10-Q · filed 2022-08-08 | |||||
| 2021-03-31 | 9.64M shares 10-Q · filed 2022-05-09 | ||||||
| 2020-12-31 | 9.01M shares 10-K · filed 2023-02-21 | ||||||
| 2020-09-30 | 8.84M shares 10-Q · filed 2021-11-03 | 8.84M shares 10-Q · filed 2021-11-03 | |||||
| 2020-06-30 | 9.13M shares 10-Q · filed 2021-07-29 | 9.13M shares 10-Q · filed 2021-07-29 | 8.21M shares 10-Q · filed 2020-07-27 | ||||
| 2020-03-31 | 9.46M shares 10-Q · filed 2021-04-27 | ||||||
| 2019-12-31 | 3.90M shares 10-K · filed 2022-02-15 | ||||||
| 2019-09-30 | 3.81M shares 10-Q · filed 2020-10-28 | 2.77M shares 10-Q · filed 2019-10-28 | 3.95M shares 10-Q · filed 2020-10-28 | 2.44M shares 10-Q · filed 2019-10-28 | |||
| 2019-06-30 | 8.20M shares 10-Q · filed 2020-07-27 | 8.53M shares 10-Q · filed 2019-07-29 | |||||
| 2019-03-31 | 8.38M shares 10-Q · filed 2020-04-28 | ||||||
| 2018-12-31 | 7.02M shares 10-K · filed 2021-02-16 | ||||||
| 2018-09-30 | 6.88M shares 10-Q · filed 2019-10-28 | 6.88M shares 10-Q · filed 2019-10-28 | |||||
| 2018-06-30 | 6.79M shares 10-Q · filed 2019-07-29 | ||||||
| 2018-03-31 | 6.79M shares 10-Q · filed 2019-04-29 | 6.69M shares 10-Q · filed 2018-05-08 | |||||
| 2017-12-31 | 6.42M shares 10-K · filed 2020-02-12 | ||||||
| 2017-09-30 | 5.84M shares 10-Q · filed 2018-11-07 | 5.84B shares 10-Q · filed 2017-11-08 | |||||
| 2017-06-30 | 5.71M shares 10-Q · filed 2018-08-07 | 5.71B shares 10-Q · filed 2017-08-10 | |||||
| 2017-03-31 | 4.91M shares 10-Q · filed 2018-05-08 | 4.91B shares 10-Q · filed 2017-05-11 | |||||
| 2016-12-31 | 4.62M shares 10-K · filed 2019-02-25 | ||||||
| 2016-09-30 | 31.33B shares 10-Q · filed 2016-11-22 | 31.33B shares 10-Q · filed 2016-11-22 | |||||
| 2016-03-31 | 27.16B shares 10-Q · filed 2017-05-11 | ||||||
| 2015-12-31 | 25.36M shares 10-K · filed 2018-03-08 | ||||||
| 2015-09-30 | 21.00B shares 10-Q · filed 2016-11-22 | 21.00B shares 10-Q · filed 2016-11-22 | |||||
| 2014-12-31 | 3.56M shares 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |